Health Care Equipment

Teleflex

Wolfe Research Lowers Teleflex 2029 Fiscal Year EPS Forecast to $14.19

Needham Predicts TELA Earnings at $2.90 Per Share for Q1 2028

Wall Street Zen Downgrades Teleflex Stock Rating to Sell

Teleflex Reports Q1 2026 Earnings and Launches Share Repurchase Program

Teleflex released FY2026 Q1 earnings on May 7 Pre-Market (EST), actual revenue USD 548.26 M (forecast USD 537.59 M), actual EPS USD -0.1849 (forecast USD 0.3466)

Teleflex to Release FY2026 Q1 Earnings on May 7 Pre-Market EST, Forecast Revenue USD 537.59 M, EPS USD 0.3466

Private Equity Firms Considering Acquisition of Teleflex

BofA Global Research Upgrades Teleflex's Stock Rating and Price Target

Irenic Capital Urges Tyco to Form Strategic Review Panel

Irenic Capital Management urges Teleflex Inc. to approach potential buyers

Terumo Denies Acquisition Talks and Keeps Open to Proposals

Takeda Receives FTC Request for Additional Information on Transaction

Teleflex released FY2025 Q4 earnings on February 26 Pre-Market (EST), actual revenue USD 568.98 M (forecast USD 914.95 M), actual EPS USD -16.1474 (forecast USD -0.065)

Terumo forecasts FY23 EPS

Teleflex Reports Q4 Earnings

Teleflex to Release FY2025 Q4 Earnings on February 26 Pre-Market EST, Forecast Revenue USD 912.57 M, EPS USD -0.07

Needham & Company LLC Downgrades Teleflex Incorporated Earnings Estimate but Maintains Buy Rating

RBC Capital Analyst Maintains Hold Rating on Teleflex

Teleflex Cuts 2025 Revenue Forecast, Shares Fall 12.5%

Raymond James and Truist Financial Maintain Hold Rating on Teleflex

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Ordinary dividend (cash)

Ex Date: 2026.05.22 (EST), Cash dividend 0.34 USD

Teleflex (TFX) reported better-than-expected quarterly earnings, driven by its Vascular Intervention acquisition and steady demand. Despite a recent 23.19% share price increase, the 5-year total shareholder return is down 66.58%. Analysts suggest TFX is slightly overvalued at $130.41, with a fair value estimate of $129.25. However, a DCF model indicates a potential future cash flow value of $223.56, suggesting market pricing may reflect execution risks. Investors are encouraged to consider both opportunities and risks in their analysis.

Simplywall

A Look At Teleflex (TFX) Valuation After Quarterly Earnings Beat And Vascular Intervention Integration Progress

Teleflex Incorporated (NYSE: TFX) has declared a quarterly cash dividend of $0.34 per share, payable on June 30, 2026, to shareholders of record by May 25, 2026. The company focuses on improving healthcare through innovative medical technologies across various therapy areas.

StockTitan

Teleflex Announces Quarterly Dividend | TFX Stock News

Analysts at Wolfe Research have lowered their FY2029 earnings per share (EPS) estimate for Teleflex Incorporated (NYSE: TFX) from $15.36 to $14.19. The current consensus estimate for FY2023 earnings is $6.69 per share. Teleflex recently reported a quarterly EPS of $1.39, exceeding expectations. The company has a market cap of $5.75 billion and a dividend yield of 1.0%. Institutional investors hold 95.62% of the stock. Despite a positive earnings report, analysts have mixed ratings on the stock, with an average rating of "Hold" and a price target of $144.00.

Market Beat

ROYAL BANK OF CANADA

Truist Financial

Wells Fargo

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Analysts Set Expectations for Teleflex FY2029 Earnings

Teleflex Incorporated (NYSE:TFX) has received Q1 2028 earnings per share estimates from Needham & Company LLC, predicting $2.90 EPS. The firm maintains a "Buy" rating with a $147.00 price target. Teleflex's recent quarterly earnings were $1.39 EPS, exceeding estimates. Analysts have mixed ratings, with three Buy, five Hold, and one Sell. The stock opened at $129.92, with a market cap of $5.75 billion. The company also declared a quarterly dividend of $0.34 per share.

Raymond James Financial

Invesco

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

Research Analysts Issue Forecasts for Teleflex Q1 Earnings

Medtronic PLC (MDT) shares fell 2.11% to $74.54 on Monday, marking its second consecutive day of losses, despite a positive trading session for the stock market. The stock is currently 29.90% below its 52-week high of $106.33. In comparison, Johnson & Johnson rose 0.05%, while Danaher Corp. and Abbott Laboratories saw declines of 2.71% and 2.09%, respectively. Trading volume for Medtronic was 10.3 million, surpassing its 50-day average of 8.7 million.

MarketWatch Automated

Medtronic

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

SPDR S&P Health Equip

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

iShares US Medical Devices

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Danaher

Abbott Laboratories

Factset Research

Medtronic PLC Stock Underperforms Monday When Compared To Competitors

Wall Street Zen downgraded Teleflex (NYSE: TFX) from a "hold" to a "sell" rating. Other analysts have mixed views, with Raymond James maintaining an "outperform" rating and a $150 price target, while Weiss Ratings reaffirmed a "sell" rating. Teleflex's stock opened at $133.17, with a 12-month high of $139.67. The company reported Q1 earnings of $1.39 per share, exceeding estimates, and revenue of $548.3 million. Hedge funds hold 95.62% of the stock, indicating strong institutional interest.

Mizuho Financial

Bank of America

Janus Henderson

State Street

Mizuho Financial Group, Inc.

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

State Street® US Equity Premium Inc ETF

Teleflex (NYSE:TFX) Rating Lowered to Sell at Wall Street Zen

Teleflex (TFX) stock closed at $131.68, showing short-term momentum with a 6.9% one-day return and a 14.0% return over 30 days. However, it has a 45.9% decline in total shareholder return over three years. Analysts suggest a fair value of $129.25, indicating the stock is slightly overvalued. A discounted cash flow model estimates a future cash flow value of $238.50, suggesting potential upside. Investors are advised to consider risks and opportunities in the healthcare sector, including other undervalued stocks and resilient investments.

Assessing Teleflex (TFX) Valuation After Recent Share Price Momentum and Mixed Fair Value Signals

Teleflex Inc. (TFX) shares rose 1.05% to $133.06 on a positive trading day, marking its fourth consecutive gain. The stock is 4.73% below its 52-week high of $139.67. In contrast, competitors like Johnson & Johnson, Medtronic, and Boston Scientific saw declines. The trading volume for Teleflex was 947,200, surpassing its 50-day average of 923,047. The S&P 500 Index increased by 0.84% and the Dow Jones Industrial Average by 0.02%.

Boston Scientific

Teleflex Inc. Stock Outperforms Competitors On Strong Trading Day

Teleflex(TFX.US)